BioMarin Begins Phase II Study Of 6R-BH4 For Sickle Cell Disease
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm initiates treatment in sickle cell patients after stalling Phase IIb study of molecule in treatment of hypertension earlier this year.